Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy

Paul William Foley, Kayvan Khadjooi, Shajil Chalil, Russell E. A. Smith, Selvakumar Ramachandran, Michael Frenneaux, Francisco Leyva

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)A356-357
Number of pages2
JournalJournal of the American College of Cardiology
Volume51
Issue number10 Suppl. A
Publication statusPublished - 11 Mar 2008

Cite this

Foley, P. W., Khadjooi, K., Chalil, S., Smith, R. E. A., Ramachandran, S., Frenneaux, M., & Leyva, F. (2008). Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy. Journal of the American College of Cardiology, 51(10 Suppl. A), A356-357.

Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy. / Foley, Paul William; Khadjooi, Kayvan; Chalil, Shajil; Smith, Russell E. A.; Ramachandran, Selvakumar; Frenneaux, Michael; Leyva, Francisco.

In: Journal of the American College of Cardiology, Vol. 51, No. 10 Suppl. A, 11.03.2008, p. A356-357.

Research output: Contribution to journalAbstract

Foley, PW, Khadjooi, K, Chalil, S, Smith, REA, Ramachandran, S, Frenneaux, M & Leyva, F 2008, 'Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy', Journal of the American College of Cardiology, vol. 51, no. 10 Suppl. A, pp. A356-357.
Foley PW, Khadjooi K, Chalil S, Smith REA, Ramachandran S, Frenneaux M et al. Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy. Journal of the American College of Cardiology. 2008 Mar 11;51(10 Suppl. A):A356-357.
Foley, Paul William ; Khadjooi, Kayvan ; Chalil, Shajil ; Smith, Russell E. A. ; Ramachandran, Selvakumar ; Frenneaux, Michael ; Leyva, Francisco. / Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy. In: Journal of the American College of Cardiology. 2008 ; Vol. 51, No. 10 Suppl. A. pp. A356-357.
@article{f22880a7b4704f20aa9d83238f016c7d,
title = "Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy",
author = "Foley, {Paul William} and Kayvan Khadjooi and Shajil Chalil and Smith, {Russell E. A.} and Selvakumar Ramachandran and Michael Frenneaux and Francisco Leyva",
year = "2008",
month = "3",
day = "11",
language = "English",
volume = "51",
pages = "A356--357",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "10 Suppl. A",

}

TY - JOUR

T1 - Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy

AU - Foley, Paul William

AU - Khadjooi, Kayvan

AU - Chalil, Shajil

AU - Smith, Russell E. A.

AU - Ramachandran, Selvakumar

AU - Frenneaux, Michael

AU - Leyva, Francisco

PY - 2008/3/11

Y1 - 2008/3/11

M3 - Abstract

VL - 51

SP - A356-357

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 10 Suppl. A

ER -